Acamprosate for alcohol use disorder
https://libcat.nshealth.ca/en/permalink/chpams37562
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2268
- Available Online
- View Pamphlet
Acamprosate is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol fully, not just drink less. This pamphlet explains how to take this medication, whether acamprosate interacts with other medications, what will happen if you drink alcohol while taking acamprosate, how long you will need to take acamprosate, possible side effects, and how much acamprosate costs.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Acamprosate
- Alcohol-Related Disorders - therapy
- Alcoholism - drug therapy
- Subjects (LCSH)
- Acamprosate
- Alcoholism--Treatment
- Specialty
- Medications
- Abstract
- Acamprosate is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol fully, not just drink less. This pamphlet explains how to take this medication, whether acamprosate interacts with other medications, what will happen if you drink alcohol while taking acamprosate, how long you will need to take acamprosate, possible side effects, and how much acamprosate costs.
- Notes
- Previous title: Acamprosate for alcohol dependence
- Responsibility
- Prepared by: Pharmacy Services, Aberdeen Hospital
- Pamphlet Number
- 2268
ACE inhibitors
https://libcat.nshealth.ca/en/permalink/chpams38250
Nova Scotia Health Authority. QEII. Pharmacy Department.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 0613
- Available Online
- View Pamphlet
Angiotensin converting enzyme (ACE) inhibitors are medications that can be used to treat high blood pressure and certain heart conditions (like heart attacks, heart failure), and kidney disease. This pamphlet explains how to take and store these medications. Possible side effects are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Department
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Angiotensin-Converting Enzyme Inhibitors
- Subjects (LCSH)
- Angiotensin converting enzyme--Inhibitors
- Specialty
- Medications
- Abstract
- Angiotensin converting enzyme (ACE) inhibitors are medications that can be used to treat high blood pressure and certain heart conditions (like heart attacks, heart failure), and kidney disease. This pamphlet explains how to take and store these medications. Possible side effects are listed.
- Responsibility
- Prepared by: Pharmacy Department
- Pamphlet Number
- 0613
Adalimumab therapy for inflammatory bowel disease (IBD)
https://libcat.nshealth.ca/en/permalink/chpams35127
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1207
- Available Online
- View Pamphlet
Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
- Alternate Title
- Adalimumab therapy for IBD
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (11 p.) : digital, PDF file
- Subjects (MeSH)
- Adalimumab
- Inflammatory Bowel Diseases - drug therapy
- Subjects (LCSH)
- Inflammatory bowel diseases
- Specialty
- Medications
- Abstract
- Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
- Notes
- Previous title: Adalimumab (Humira) therapy
- Responsibility
- Prepared by: Nova Scotia Collaborative IBD Program
- Pamphlet Number
- 1207
Aripiprazole (Abilify, Abilify Maintena)
https://libcat.nshealth.ca/en/permalink/chpams35626
Nova Scotia Health Authority. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1627
- Available Online
- View Pamphlet
Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Aripiprazole
- Subjects (LCSH)
- Antipsychotic drugs
- Specialty
- Medications
- Abstract
- Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
- Responsibility
- Prepared by: Pharmacy Services
- Pamphlet Number
- 1627
Nova Scotia Health Authority. QEII. Pharmacy Department.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 0071
- Available Online
- View Pamphlet
The pamphlet explains what Aspirin® is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are also listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Department
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Aspirin
- Subjects (LCSH)
- Aspirin
- Specialty
- Medications
- Abstract
- The pamphlet explains what Aspirin® is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are also listed.
- Responsibility
- Prepared by: Pharmacy Department
- Pamphlet Number
- 0071
Azathioprine or mercaptopurine therapy for inflammatory bowel disease (IBD)
https://libcat.nshealth.ca/en/permalink/chpams35565
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 1079
- Available Online
- View Pamphlet
Azathioprine (Imuran®) or mercaptopurine may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about combination therapy in IBD, possible side effects of these medications, and what you can do to lower the chance of side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Alternate Title
- Azathioprine or mercaptopurine therapy for IBD
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.): digital, PDF file
- Subjects (MeSH)
- Immunosuppressive Agents
- Azathioprine
- Mercaptopurine
- Subjects (LCSH)
- Immunosuppressive agents
- Specialty
- Medications
- Abstract
- Azathioprine (Imuran®) or mercaptopurine may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about combination therapy in IBD, possible side effects of these medications, and what you can do to lower the chance of side effects.
- Notes
- Previous title: Azathioprine (Imuran) therapy
- Previous title: Azathioprine and mercaptopurine therapy
- Responsibility
- Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Pamphlet Number
- 1079
Benzodiazepines for alcohol withdrawal
https://libcat.nshealth.ca/en/permalink/chpams37554
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2262
- Available Online
- View Pamphlet
Benzodiazepines are a group of medications that work as sedatives. They are commonly called “benzos”. Diazepam and lorazepam are 2 benzodiazepines used to manage all stages of alcohol withdrawal. This pamphlet explains how to take this medication, how benzodiazepines help, how your prescriber will decide which benzodiazepine is right for you, how much medication you will need, and possible side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (LCSH)
- Benzodiazepines
- Alcoholism--Treatment
- Specialty
- Medications
- Abstract
- Benzodiazepines are a group of medications that work as sedatives. They are commonly called “benzos”. Diazepam and lorazepam are 2 benzodiazepines used to manage all stages of alcohol withdrawal. This pamphlet explains how to take this medication, how benzodiazepines help, how your prescriber will decide which benzodiazepine is right for you, how much medication you will need, and possible side effects.
- Responsibility
- Prepared by: Pharmacy Services, Aberdeen Hospital
- Pamphlet Number
- 2262
Beta blockers
https://libcat.nshealth.ca/en/permalink/chpams38249
Nova Scotia Health Authority. QEII. Pharmacy Department.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 0294
- Available Online
- View Pamphlet
Beta blockers are medications used to treat high blood pressure and angina (chest pain), and to lower the risk of repeated heart attacks. This pamphlet explains how to take and store these medications. Possible side effects are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Department
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Adrenergic Agents
- Subjects (LCSH)
- Adrenergic beta blockers
- Specialty
- Medications
- Abstract
- Beta blockers are medications used to treat high blood pressure and angina (chest pain), and to lower the risk of repeated heart attacks. This pamphlet explains how to take and store these medications. Possible side effects are listed.
- Responsibility
- Prepared by: Pharmacy Department
- Pamphlet Number
- 0294
Bowel preparation for chronic kidney disease before colonoscopy
https://libcat.nshealth.ca/en/permalink/chpams35387
Nova Scotia Health Authority. Renal Program, Nova Scotia Health Authority. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2020.
- Pamphlet Number
- 1475
- Available Online
- View Pamphlet
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Nova Scotia Health Authority. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2020
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Cathartics
- Colonoscopy
- Renal Insufficiency, Chronic
- Subjects (LCSH)
- Laxatives
- Colonoscopy
- Chronic renal failure
- Specialty
- Medications
- Nephrology
- Abstract
- This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
- Responsibility
- Prepared by: NSHA Renal Program Educators and Pharmacists
- Pamphlet Number
- 1475
Buprenorphine for opioid use disorder
https://libcat.nshealth.ca/en/permalink/chpams37561
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2267
- Available Online
- View Pamphlet
Buprenorphine is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a longer time. This pamphlet explains how to take this medication, how fast buprenorphine starts to work, how your health care team will find the right dose for you, and how long you will need to take buprenorphine. Information on whether buprenorphine interacts with any other medications and possible side effects is included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Buprenorphine
- Opioid-Related Disorders - therapy
- Subjects (LCSH)
- Buprenorphine
- Opioid abuse
- Specialty
- Medications
- Abstract
- Buprenorphine is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a longer time. This pamphlet explains how to take this medication, how fast buprenorphine starts to work, how your health care team will find the right dose for you, and how long you will need to take buprenorphine. Information on whether buprenorphine interacts with any other medications and possible side effects is included.
- Responsibility
- Prepared by: Pharmacy Services, Aberdeen Hospital
- Pamphlet Number
- 2267
Nova Scotia Health Authority. QEII. Pharmacy Department.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 0249
- Available Online
- View Pamphlet
This pamphlet explains what clopidogrel is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QEII. Pharmacy Department
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (4 p.) : digital, PDF file
- Subjects (MeSH)
- Anticoagulants
- Subjects (LCSH)
- Anticoagulants (Medicine)
- Specialty
- Medications
- Abstract
- This pamphlet explains what clopidogrel is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are listed.
- Responsibility
- Prepared by: Pharmacy Department
- Pamphlet Number
- 0249
Corticosteroid therapy for inflammatory bowel disease (IBD)
https://libcat.nshealth.ca/en/permalink/chpams35480
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 1546
- Available Online
- View Pamphlet
A corticosteroid medication may help you manage your inflammatory bowel disease (IBD). This pamphlet explains what corticosteroids are, how well they work, and how they are given. Information about precautions, possible side effects, and what to expect after your treatment is included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Alternate Title
- Corticosteroid therapy for IBD
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (10 p.) : digital, PDF file
- Subjects (MeSH)
- Inflammatory Bowel Diseases - drug therapy
- Prednisone
- Subjects (LCSH)
- Inflammatory bowel diseases
- Prednisone
- Specialty
- Medications
- Abstract
- A corticosteroid medication may help you manage your inflammatory bowel disease (IBD). This pamphlet explains what corticosteroids are, how well they work, and how they are given. Information about precautions, possible side effects, and what to expect after your treatment is included.
- Notes
- This pamphlet replaced pamphlet 1139: Prednisone Therapy
- Previous title: Corticosteroid therapy in inflammatory bowel disease (IBD)
- Responsibility
- Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Pamphlet Number
- 1546
Cytomegalovirus (CMV)
https://libcat.nshealth.ca/en/permalink/chpams36606
Nova Scotia Health Authority. Kidney Transplant Clinic.
Halifax, NS:
Nova Scotia Health Authority
, 2019.
- Pamphlet Number
- 1999
- Available Online
- View Pamphlet
The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Kidney Transplant Clinic
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([1] p.) : digital, PDF file
- Subjects (MeSH)
- Cytomegalovirus
- Kidney Transplantation - adverse effects
- Immunosuppressive Agents - adverse effects
- Specialty
- Nephrology
- Medications
- Abstract
- The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
- Responsibility
- Prepared by: Kidney Transplant Clinic
- Pamphlet Number
- 1999
Cytotoxic precautions at home
https://libcat.nshealth.ca/en/permalink/chpams37335
Nova Scotia Health. Nova Scotia Cell Therapy and Transplant Program.
Halifax, NS:
Nova Scotia Health Cancer Care Program
, 2022.
- Pamphlet Number
- 4037
- Available Online
- View Pamphlet
You are being treated with a cancer treatment that is cytotoxic. This means it can kill cancer cells and can harm healthy cells. This booklet describes what you, your family, friends and caregivers need to know about cytotoxic precautions. These precautions are used to keep your family members, friends and caregivers safe while you are taking your cancer treatment. This pamphlet explains what cytotoxic precautions are, what body fluids are cytotoxic, how to handle your body wastes, what to do …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health. Nova Scotia Cell Therapy and Transplant Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Cancer Care Program
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Neoplasms - drug therapy
- Patient Safety
- Cytotoxins--toxicity
- Subjects (LCSH)
- Cancer--Chemotherapy
- Patient safety
- Specialty
- Cancer Care
- Medications
- Abstract
- You are being treated with a cancer treatment that is cytotoxic. This means it can kill cancer cells and can harm healthy cells. This booklet describes what you, your family, friends and caregivers need to know about cytotoxic precautions. These precautions are used to keep your family members, friends and caregivers safe while you are taking your cancer treatment. This pamphlet explains what cytotoxic precautions are, what body fluids are cytotoxic, how to handle your body wastes, what to do if your body wastes spill and what to do with the garbage. Information about dishes, laundry, sex, having a baby, breastfeeding, and how to bring samples to the hospital is included.
- Responsibility
- Prepared by: Nova Scotia Cell Therapy and Transplant Program
- Pamphlet Number
- 4037
Disulfiram for alcohol dependence
https://libcat.nshealth.ca/en/permalink/chpams37563
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2269
- Available Online
- View Pamphlet
Disulfiram is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol completely, not just drink less. This pamphlet explains how to take this medication, what will happen if you drink alcohol while taking disulfiram, how well disulfiram works, whether disulfiram interacts with other medications or foods, and how long you will need to take this medication. Possible side effects are included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Disulfiram
- Alcohol-Related Disorders - therapy
- Alcoholism - drug therapy
- Subjects (LCSH)
- Disulfiram
- Alcoholism--Treatment
- Specialty
- Medications
- Abstract
- Disulfiram is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol completely, not just drink less. This pamphlet explains how to take this medication, what will happen if you drink alcohol while taking disulfiram, how well disulfiram works, whether disulfiram interacts with other medications or foods, and how long you will need to take this medication. Possible side effects are included.
- Responsibility
- Prepared by: Pharmacy Services, Aberdeen Hospital
- Pamphlet Number
- 2269
Golimumab (Simponi®) for inflammatory bowel disease (IBD)
https://libcat.nshealth.ca/en/permalink/chpams35651
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1641
- Available Online
- View Pamphlet
Your health care provider feels that treatment with golimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
- Alternate Title
- Golimumab (Simponi®) for IBD
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (12 p.) : digital, PDF file
- Subjects (MeSH)
- Golimumab
- Inflammatory Bowel Diseases - drug therapy
- Subjects (LCSH)
- Inflammatory bowel diseases
- Specialty
- Medications
- Abstract
- Your health care provider feels that treatment with golimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
- Notes
- Previous title: Golimumab (Simponi) therapy
- Responsibility
- Prepared by: Nova Scotia Collaborative IBD Program
- Pamphlet Number
- 1641
Nova Scotia Health Authority. QE II. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2023.
- Pamphlet Number
- 1937
- Available Online
- View Pamphlet
Lithium is a mood stabilizer. It is most often used in bipolar disorder to prevent or treat mania or depression. This pamphlet explains what symptoms lithium will help with, how your dose of lithium is chosen, possible side effects, and signs of lithium toxicity (too much lithium).
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. QE II. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2023
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (6 p.) : digital, PDF file
- Subjects (MeSH)
- Lithium - therapeutic use
- Bipolar Disorder - drug therapy
- Mania - drug therapy
- Depression, Bipolar - drug therapy
- Subjects (LCSH)
- Lithium--Therapeutic use
- Manic-depressive illness
- Specialty
- Medications
- Abstract
- Lithium is a mood stabilizer. It is most often used in bipolar disorder to prevent or treat mania or depression. This pamphlet explains what symptoms lithium will help with, how your dose of lithium is chosen, possible side effects, and signs of lithium toxicity (too much lithium).
- Responsibility
- Prepared by: Pharmacy Services, QE II
- Pamphlet Number
- 1937
Methadone for opioid use disorder
https://libcat.nshealth.ca/en/permalink/chpams37548
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2259
- Available Online
- View Pamphlet
Methadone is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a long time. This pamphlet explains how to take this medication, how fast methadone starts to work, how your health care team will find the right dose for you, and how long you will need to take methadone. Information about interactions with other medications and possible side effects is included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Methadone
- Subjects (LCSH)
- Methadone hydrochloride
- Specialty
- Medications
- Abstract
- Methadone is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a long time. This pamphlet explains how to take this medication, how fast methadone starts to work, how your health care team will find the right dose for you, and how long you will need to take methadone. Information about interactions with other medications and possible side effects is included.
- Responsibility
- Prepared by: Pharmacy Services, Aberdeen Hospital
- Pamphlet Number
- 2259
Methotrexate (MTX) therapy for inflammatory bowel disease (IBD)
https://libcat.nshealth.ca/en/permalink/chpams34942
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program.
Halifax, NS:
Nova Scotia Health Authority
, 2024.
- Pamphlet Number
- 1138
- Available Online
- View Pamphlet
Methotrexate (MTX) may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about what MTX is, combination therapy in IBD, who should not take MTX, how MTX is given, and possible side effects, and what you can do to lower the chance of side effects.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Alternate Title
- Methotrexate (MTX) therapy for IBD
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2024
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (13 p.) : digital, PDF file
- Subjects (MeSH)
- Methotrexate
- Inflammatory Bowel Diseases
- Immunosuppressive Agents
- Subjects (LCSH)
- Methotrexate
- Immunosuppressive agents
- Inflammatory bowel diseases
- Specialty
- Medications
- Abstract
- Methotrexate (MTX) may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about what MTX is, combination therapy in IBD, who should not take MTX, how MTX is given, and possible side effects, and what you can do to lower the chance of side effects.
- Responsibility
- Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
- Pamphlet Number
- 1138
Naltrexone for alcohol use disorder
https://libcat.nshealth.ca/en/permalink/chpams37555
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 2263
- Available Online
- View Pamphlet
Naltrexone is a medication used to help manage alcohol dependence. This medication works on the reward pathways in the brain by lowering the good feeling you get from drinking alcohol. Naltrexone may help you drink less. This pamphlet explains how to take this medication, how well naltrexone works, whether naltrexone interacts with other medications, what will happen if you drink alcohol while taking naltrexone, how long you will need to take naltrexone, possible side effects, and how much nalt…
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Naltrexone
- Alcohol-Related Disorders - therapy
- Alcoholism - drug therapy
- Subjects (LCSH)
- Naltrexone
- Alcoholism--Treatment
- Specialty
- Medications
- Abstract
- Naltrexone is a medication used to help manage alcohol dependence. This medication works on the reward pathways in the brain by lowering the good feeling you get from drinking alcohol. Naltrexone may help you drink less. This pamphlet explains how to take this medication, how well naltrexone works, whether naltrexone interacts with other medications, what will happen if you drink alcohol while taking naltrexone, how long you will need to take naltrexone, possible side effects, and how much naltrexone costs.
- Notes
- Previous title: Naltrexone for alcohol dependence
- Responsibility
- Prepared by: Pharmacy Services, Aberdeen Hospital
- Pamphlet Number
- 2263
